170 related articles for article (PubMed ID: 15077161)
1. Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A.
Tonini T; Bagella L; D'Andrilli G; Claudio PP; Giordano A
Oncogene; 2004 Jun; 23(28):4930-7. PubMed ID: 15077161
[TBL] [Abstract][Full Text] [Related]
2. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter.
Stiegler P; De Luca A; Bagella L; Giordano A
Cancer Res; 1998 Nov; 58(22):5049-52. PubMed ID: 9823308
[TBL] [Abstract][Full Text] [Related]
3. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
4. Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements.
Tonini T; D'Andrilli G; Fucito A; Gaspa L; Bagella L
J Cell Physiol; 2008 Feb; 214(2):295-300. PubMed ID: 17786943
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer.
Chen H; Tu SW; Hsieh JT
J Biol Chem; 2005 Jun; 280(23):22437-44. PubMed ID: 15817459
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of pRb2/p130, VEGF, EZH2, p53, p16, p21waf-1, p27, and PCNA in Barrett's esophagus.
Merola E; Mattioli E; Minimo C; Zuo W; Rabitti C; Cicala M; Caviglia R; Pollice L; Gabbrielli A; Giordano A; Claudio PP
J Cell Physiol; 2006 May; 207(2):512-9. PubMed ID: 16447267
[TBL] [Abstract][Full Text] [Related]
7. Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop.
Howard CM; Claudio PP; De Luca A; Stiegler P; Jori FP; Safdar NM; Caputi M; Khalili K; Giordano A
Cancer Res; 2000 May; 60(10):2737-44. PubMed ID: 10825149
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer.
Mattioli E; Vogiatzi P; Sun A; Abbadessa G; Angeloni G; D'Ugo D; Trani D; Gaughan JP; Vecchio FM; Cevenini G; Persiani R; Giordano A; Claudio PP
J Cell Physiol; 2007 Jan; 210(1):183-91. PubMed ID: 16998811
[TBL] [Abstract][Full Text] [Related]
9. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation.
Caretti G; Di Padova M; Micales B; Lyons GE; Sartorelli V
Genes Dev; 2004 Nov; 18(21):2627-38. PubMed ID: 15520282
[TBL] [Abstract][Full Text] [Related]
10. pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleus.
Zini N; Trimarchi C; Claudio PP; Stiegler P; Marinelli F; Maltarello MC; La Sala D; De Falco G; Russo G; Ammirati G; Maraldi NM; Giordano A; Cinti C
J Cell Physiol; 2001 Oct; 189(1):34-44. PubMed ID: 11573202
[TBL] [Abstract][Full Text] [Related]
11. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin.
Tong ZT; Cai MY; Wang XG; Kong LL; Mai SJ; Liu YH; Zhang HB; Liao YJ; Zheng F; Zhu W; Liu TH; Bian XW; Guan XY; Lin MC; Zeng MS; Zeng YX; Kung HF; Xie D
Oncogene; 2012 Feb; 31(5):583-94. PubMed ID: 21685935
[TBL] [Abstract][Full Text] [Related]
12. Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer.
Bohrer LR; Chen S; Hallstrom TC; Huang H
Endocrinology; 2010 Nov; 151(11):5136-45. PubMed ID: 20881251
[TBL] [Abstract][Full Text] [Related]
13. 3-Methylcholanthrene, an AhR agonist, caused cell-cycle arrest by histone deacetylation through a RhoA-dependent recruitment of HDAC1 and pRb2 to E2F1 complex.
Chang CC; Sue YM; Yang NJ; Lee YH; Juan SH
PLoS One; 2014; 9(3):e92793. PubMed ID: 24658119
[TBL] [Abstract][Full Text] [Related]
14. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation.
Raschellà G; Tanno B; Bonetto F; Amendola R; Battista T; De Luca A; Giordano A; Paggi MG
J Cell Biochem; 1997 Dec; 67(3):297-303. PubMed ID: 9361185
[TBL] [Abstract][Full Text] [Related]
15. Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma.
Claudio PP; Zamparelli A; Garcia FU; Claudio L; Ammirati G; Farina A; Bovicelli A; Russo G; Giordano GG; McGinnis DE; Giordano A; Cardi G
Clin Cancer Res; 2002 Jun; 8(6):1808-15. PubMed ID: 12060621
[TBL] [Abstract][Full Text] [Related]
16. Expression of cell cycle-regulated proteins pRB2/p130, p107, E2F4, p27, and pCNA in salivary gland tumors: prognostic and diagnostic implications.
Russo G; Zamparelli A; Howard CM; Minimo C; Bellan C; Carillo G; Califano L; Leoncini L; Giordano A; Claudio PP
Clin Cancer Res; 2005 May; 11(9):3265-73. PubMed ID: 15867222
[TBL] [Abstract][Full Text] [Related]
17. pRb2/p130 promotes radiation-induced cell death in the glioblastoma cell line HJC12 by p73 upregulation and Bcl-2 downregulation.
Pucci B; Claudio PP; Masciullo V; Bellincampi L; Terrinoni A; Khalili K; Melino G; Giordano A
Oncogene; 2002 Aug; 21(38):5897-905. PubMed ID: 12185589
[TBL] [Abstract][Full Text] [Related]
18. Activated p53 suppresses the histone methyltransferase EZH2 gene.
Tang X; Milyavsky M; Shats I; Erez N; Goldfinger N; Rotter V
Oncogene; 2004 Jul; 23(34):5759-69. PubMed ID: 15208672
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 recruits histone deacetylase 1 to a p130 repressor complex in transgenic mice in vivo.
Bouzahzah B; Fu M; Iavarone A; Factor VM; Thorgeirsson SS; Pestell RG
Cancer Res; 2000 Aug; 60(16):4531-7. PubMed ID: 10969803
[TBL] [Abstract][Full Text] [Related]
20. EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor.
Hwang C; Giri VN; Wilkinson JC; Wright CW; Wilkinson AS; Cooney KA; Duckett CS
Breast Cancer Res Treat; 2008 Jan; 107(2):235-42. PubMed ID: 17453341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
